Variant report
Variant | nsv870518 |
---|---|
Chromosome Location | chr1:80226910-80267607 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7555387 | chr1:80242036-80242037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528334151 | chr1:80242096-80242097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540432320 | chr1:80242108-80242109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529041407 | chr1:80242157-80242158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532338383 | chr1:80242161-80242162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7555511 | chr1:80242227-80242228 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs568840842 | chr1:80242230-80242231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376221786 | chr1:80242250-80242251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185394657 | chr1:80242255-80242256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547831425 | chr1:80242284-80242285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567950189 | chr1:80242290-80242291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs66826514 | chr1:80242305-80242306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370006556 | chr1:80242307-80242308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs398102926 | chr1:80242309-80242310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs58813042 | chr1:80242324-80242325 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs557360631 | chr1:80242343-80242344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546878345 | chr1:80242362-80242363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146422137 | chr1:80242369-80242370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189110519 | chr1:80242395-80242396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538824642 | chr1:80242419-80242420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138072488 | chr1:80242425-80242426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192208394 | chr1:80242456-80242457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557604250 | chr1:80242490-80242491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10874073 | chr1:80242510-80242511 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs74964317 | chr1:80242524-80242525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573188954 | chr1:80242535-80242536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184588669 | chr1:80242577-80242578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs74615443 | chr1:80242587-80242588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs12023389 | chr1:80242598-80242599 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs528558619 | chr1:80242657-80242658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544394382 | chr1:80242658-80242659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562620876 | chr1:80242731-80242732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529705696 | chr1:80242818-80242819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548261201 | chr1:80242821-80242822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188482130 | chr1:80242840-80242841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553665055 | chr1:80242854-80242855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs527275550 | chr1:80242864-80242865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546915261 | chr1:80242949-80242950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12024204 | chr1:80243001-80243002 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
40 | rs538862698 | chr1:80243007-80243008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542440029 | chr1:80243019-80243020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs17103689 | chr1:80243030-80243031 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs181325412 | chr1:80243034-80243035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536393523 | chr1:80243041-80243042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs116396113 | chr1:80243089-80243090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs115823454 | chr1:80243103-80243104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534163748 | chr1:80243104-80243105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs386632759 | chr1:80243116-80243117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7556171 | chr1:80243117-80243118 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs376850518 | chr1:80243137-80243138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:80242000-80243800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:80243000-80243400 | Enhancers | Fetal Heart | heart |
3 | chr1:80243000-80243800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr1:80243000-80244600 | Enhancers | GM12878-XiMat | blood |
5 | chr1:80243200-80244000 | Enhancers | Primary B cells from peripheral blood | blood |
6 | chr1:80247200-80250600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr1:80249200-80250800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr1:80249400-80251400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr1:80250600-80250800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr1:80250800-80251400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr1:80251400-80251600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr1:80251600-80257600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr1:80256800-80257200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr1:80257000-80257200 | Enhancers | Pancreas | Pancrea |
15 | chr1:80257000-80258400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
16 | chr1:80257200-80257800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
17 | chr1:80257200-80258000 | Weak transcription | Pancreas | Pancrea |
18 | chr1:80257200-80258400 | Enhancers | Aorta | Aorta |
19 | chr1:80257600-80258200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr1:80257600-80258600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
21 | chr1:80258000-80258200 | Enhancers | Pancreas | Pancrea |
22 | chr1:80258200-80267400 | Weak transcription | Pancreas | Pancrea |
23 | chr1:80262600-80262800 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
24 | chr1:80262800-80264000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
25 | chr1:80263000-80264000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |